GPR132 and type 2 diabetes mellitus: In vivo experiments demonstrated that GPR132 deficiency significantly ameliorates metabolic disturbances induced by high-fat diet feeding, establishing a strong rationale for developing selective GPR132 modulators as potential therapies for type 2 diabetes (128).